Abstract: Controversies, new risk factors and the neuroendocrine approach to fibromyalgia: can therapeutic progress be made at last?

N Z Med J 2003 May 16;116(1174):U439

[No abstract text available. See below for contact information.]

Shipton EA.

Department of Anaesthesia, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand. shiptonea@xtra.co.nz.

PMID: 12766785 [PubMed – as supplied by publisher]

1 Star2 Stars3 Stars4 Stars5 Stars (190 votes, average: 2.95 out of 5)

Leave a Reply